Lack of neutralizing antibodies against the current circulating influenza viruses during the Omicron outbreak in Hong Kong
Liang, W.; Lv, H.; Chen, C.; Sun, Y.; Hui, D. S.; Mok, C. K. P.
Show abstract
We report the seroprevalence to the circulating influenza A H1N1 and H3N2 viruses from plasma samples collected from 479 adults between 2021 and 2022. Our results show that there is lack of neutralizing antibodies to these viruses and highlight the importance of promoting influenza vaccination during the emerging of COVID-19.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Epidemiological and clinical features of SARS-CoV-2 Infection in children during the outbreak of Omicron Variant in Shanghai, March 7-March 31, 2022 92%
- A rapid and flexible microneutralization assay for serological assessment of influenza viruses 92%
- Use of the particle agglutination/particle agglutination-inhibition test for antigenic analysis of SARS-CoV-2 91%
Similar papers in this journal
- WITHDRAWN: Estimating the clinical and economic burden of medically attended influenza in South Korea, stratified by age and comorbidity: A five-season hospital-based surveillance data, 2014/15-2018/19 93%
- Antibody responses induced by trivalent inactivated influenza vaccine among pregnant and non-pregnant women in Thailand: a matched cohort study 93%
- Large-scale cross-sectional seroepidemiologic study of COVID-19 in Japan: Acquisition of herd immunity and the vaccines’ efficacy 93%
Similar papers in this journal
- Immunogenicity of a third dose viral-vectored COVID-19 vaccine after receiving two-dose inactivated vaccines in healthy adults 93%
- Impact of serum versus anticoagulant-containing plasma on influenza virusneuraminidase-based serological assays 93%
- An in-depth investigation of the safety and immunogenicity of an inactivated SARS-CoV-2 vaccine 93%
Similar papers in this journal
Similar papers in this journal
- Gamma-irradiated SARS-CoV-2 vaccine candidate, OZG-38.61.3, confers protection from SARS-CoV-2 challenge in human ACEII-transgenic mice 92%
- Genetic and potential antigenic evolution of influenza A(H1N1)pdm09 viruses circulating in Kenya during 2009-2018 influenza seasons 92%
- Multiple early introductions of SARS-CoV-2 into a global travel hub in the Middle East 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.